CTIS.eu › Cities › Netherlands › Tilburg
Tilburg
Netherlands
140 total trials
64 recruiting
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2025-523766-25-00
5
Ulcerative colitis
2024-512975-11-01
11
urothelial cancer
2024-517233-40-00
6
Perianal abscess
2025-521037-86-00
5
Immune system diseases
2025-521590-13-00
5
Moderately to Severely Active Crohn’s Disease
2025-522511-42-00
4
Crohn's disease
2025-523586-18-00
5
Non-Small Cell Lung Cancer
2025-524229-41-00
5
Triple negative breast cancer
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
2024-517700-12-00
5
2025-12-10
Rectal cancer
2024-516188-10-00
6
2025-10-07
Intracerebral haemorrhage
2024-518296-56-00
5
2025-09-29
Crohn’s Disease
2024-517410-15-01
5
2025-01-14
Rectal cancer
2023-505678-14-00
4
2024-08-19
Ulcerative Colitis
2023-504265-23-00
4
2023-10-23
Crohn's disease
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
2022-500461-28-06
5
2022-09-15
High-Risk Metastatic Hormone-Sensitive Prostate Cancer
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
2024-520014-22-00
5
2026-04-22
Locally advanced/metastatic urothelial carcinoma
2025-522338-30-00
4
2026-03-31
Ulcerative Colitis
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
2025-521036-11-00
5
2026-03-23
Immune system disseases
2024-514500-14-00
5
2025-12-15
Participants with KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous
Showing 1–24 of 140 trials